Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARGAN INC Director's Dealing 2025

May 6, 2025

31210_dirs_2025-05-06_98754cf7-5187-4aec-9522-7e78ff3614ca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARGAN INC (AGX)
CIK: 0000100591
Period of Report: 2025-04-16

Reporting Person: Baugher Joshua Scott (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-04-16 Common Stock M 538 Acquired 913 Direct
2025-04-17 Common Stock M 322 Acquired 1235 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-04-16 Time-Based Restricted Stock Units $0 M 1000 Disposed Common Stock (1000) Direct
2025-04-16 Time-Based Restricted Stock Units $0 A 2000 Acquired Common Stock (2000) Direct
2025-04-17 Time-Based Restricted Stock Units $0 M 583 Disposed Common Stock (583) Direct
2025-04-16 Option to Purchase Common Stock $148.72 A 1000 Acquired 2035-04-16 Common Stock (1000) Direct
2025-04-16 Performance-Based Restricted Stock Units $0 A 1500 Acquired Common Stock (1500) Direct
2025-04-16 Earnings Per Share Performance-Based Restricted Stock Units $0 A 3750 Acquired Common Stock (3750) Direct

Footnotes

F1: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 1,000 shares of Common Stock became issuable to the Reporting Person on April 16, 2025.

F2: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 583 shares of Common Stock became issuable to the Reporting Person on April 17, 2025.

F3: On April 16, 2025, the Reporting Person was granted TRSUs covering 2,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026.

F4: On April 16, 2025, the Reporting Person received 10-year options to purchase 1,000 shares of the Issuer's common stock with an exercise price of $148.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/16/2026.

F5: On April 16, 2025, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 1,500 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 1,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F6: On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,750 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 3,750 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.